CORC

在结果中检索

CORC

浏览/检索结果: 共143条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载：35/0  |  提交时间：2022/12/30
Athermalization design of compact dual-fields middle infrared optical zoom system with high-speed switching 会议论文
Shanghai, China, 2021-10-28
作者:  Mei, Chao;  Fei, Jia-Qi;  Ma, Ying-Jun;  Zhang, Hong-Wei
收藏  |  浏览/下载：70/0  |  提交时间：2022/03/18
Rh2S3/N-Doped Carbon Hybrids as pH-Universal Bifunctional Electrocatalysts for Energy-Saving Hydrogen Evolution 会议论文
作者:  Zhang, Chaoxiong;  Liu, Haoxuan;  Liu, Yifan;  Liu, Xijun;  Mi, Yuying
收藏  |  浏览/下载：19/0  |  提交时间：2020/12/18
Inside Front Cover: Rh2S3/N-Doped Carbon Hybrids as pH-Universal Bifunctional Electrocatalysts for Energy-Saving Hydrogen Evolution (Small Methods 9/2020) 会议论文
作者:  Zhang, Chaoxiong;  Liu, Haoxuan;  Liu, Yifan;  Liu, Xijun;  Mi, Yuying
收藏  |  浏览/下载：13/0  |  提交时间：2020/12/18
Scene Restoring for Narrative Machine Reading Comprehension 会议论文
Online, Nov 16, 2020 - Nov 20, 2020
作者:  Zhixing Tian;  Yuanzhe Zhang;  Kang Liu;  Jun Zhao;  Yantao Jia
收藏  |  浏览/下载：8/0  |  提交时间：2020/10/14
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria 会议论文
作者:  Gu Wenyi;  Deng, Guohong;  Zheng, Xin;  Chen, Jinjun;  Wang, Xian-bo
收藏  |  浏览/下载：88/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace